Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levels
Top Cited Papers
Open Access
- 30 May 2013
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 11 (8), 1493-1502
- https://doi.org/10.1111/jth.12308
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Plasma-Diluted Thrombin Time to Measure Dabigatran Concentrations During Dabigatran Etexilate TherapyAmerican Journal of Clinical Pathology, 2012
- Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatranBlood Coagulation & Fibrinolysis, 2012
- Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of DigoxinThe Journal of Clinical Pharmacology, 2012
- Impact of dabigatran on a large panel of routine or specific coagulation assaysThrombosis and Haemostasis, 2012
- Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilateThrombosis and Haemostasis, 2012
- Potential Inaccuracy of Point-of-Care INR in Dabigatran-Treated PatientsAnnals of Pharmacotherapy, 2011
- Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assaysThrombosis and Haemostasis, 2011
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran EtexilateClinical Pharmacokinetics, 2008
- Dabigatran With or Without Concomitant Aspirin Compared With Warfarin Alone in Patients With Nonvalvular Atrial Fibrillation (PETRO Study)The American Journal of Cardiology, 2007